01What Stem Cell Therapy for Lungs Disease Is
Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term covering chronic bronchitis and emphysema, both of which progressively reduce airflow and cause breathlessness. In chronic bronchitis, the airways become inflamed and clogged with mucus; in emphysema, the tiny air sacs (alveoli) lose their elasticity, trapping air and making it harder to draw in fresh oxygen.
COPD usually develops slowly after years of exposure to cigarette smoke, occupational dust and fumes, or indoor air pollution, though genetic factors such as alpha-1 antitrypsin deficiency can also play a role. Standard care — bronchodilators, inhaled steroids, oxygen therapy and pulmonary rehabilitation — can ease symptoms but cannot reverse the underlying tissue damage. This is the gap that regenerative approaches such as stem cell therapy are being studied to address, aiming to calm inflammation and support repair of damaged airway and alveolar tissue alongside conventional treatment.
02Symptoms of Lungs Disease
COPD symptoms tend to emerge gradually and are easy to dismiss at first. Common signs include:
- A persistent cough that does not go away
- Frequent coughing up of mucus
- Breathlessness, especially during physical activity
- A feeling of tightness in the chest
- Wheezing and reduced exercise tolerance
03Types of Lungs Disease
Emphysema: Damage to the walls of the alveoli causes them to lose shape and elasticity, trapping air and making it progressively harder to bring in fresh oxygen.
Chronic Bronchitis: Defined as a cough with mucus production lasting most days for at least three months a year, over two consecutive years, caused by inflamed and mucus-clogged airways.
04Causes of Lungs Disease
COPD develops from a combination of environmental, genetic and lifestyle factors, usually over many years:
- Long-term cigarette smoking, including secondhand smoke exposure
- Occupational exposure to dust, chemical fumes and industrial pollutants
- Indoor air pollution from wood, coal or biomass cooking fuels
- A family history of lung disease
- Poorly controlled asthma over many years
- Repeated childhood respiratory infections
- Rare genetic conditions such as alpha-1 antitrypsin deficiency
05How Lungs Disease Is Diagnosed
Diagnosis begins with a medical history and physical examination, supported by lung function testing (spirometry) and chest imaging. Additional tests may include arterial blood gas analysis, pulse oximetry, an ECG to rule out cardiac causes of breathlessness, and a transfer factor test to assess how well oxygen moves from the lungs into the blood.
06How Stem Cell Therapy Is Approached as a Treatment for Lungs Disease
Standard COPD management centres on bronchodilators, inhaled steroids, pulmonary rehabilitation, oxygen therapy where needed, and smoking cessation. Stem cell therapy is being explored as a supportive addition aimed at reducing airway inflammation and supporting tissue repair, drawing on cells sourced from the patient’s own bone marrow or adipose tissue.
07How It's Being Explored for Lungs Disease
COPD involves progressive narrowing of the airways from a combination of chronic bronchitis and emphysema, both of which impede normal airflow. Stem cell therapy is being investigated for its potential to lower inflammation in the airway lining, support repair of damaged alveolar walls, and encourage the release of growth factors that may aid tissue maintenance — all avenues that remain under active research rather than settled science.
08What the Lungs Disease Treatment Process Looks Like
Typical Treatment Timeline
Day 1: Airport pickup, doctor consultation, admission formalities, clinical examination and lab work, and initial supportive therapy.
Day 2: The stem cell procedure itself, along with supportive therapies and physiotherapy.
Day 3: Further supportive therapy and physiotherapy, discharge formalities, and airport drop-off.
Patients are asked to bring valid identification and hard copies of their medical reports for admission.
09Delivery Techniques Used in Stem Cell Therapy for Lungs Disease
Depending on the patient’s condition, stem cells may be delivered by intravenous infusion, intrathecal (lumbar puncture) administration, intramuscular or subcutaneous injection, intra-arterial delivery, or, in select cases, direct surgical delivery.
10Changes Lungs Disease Patients Sometimes Report
Where patients respond, reported changes include easier breathing and improved exercise tolerance, less frequent and less severe coughing, reduced mucus production, better sleep due to fewer nighttime breathing disruptions, and a general increase in energy and appetite. These are patient-reported outcomes rather than guaranteed results, and they should be interpreted alongside standard pulmonary function testing.
11Is Stem Cell Therapy Safe for Lungs Disease?
Stem cell therapy for Lungs Disease is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Lungs Disease, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.
12Who Might Consider a Lungs Disease Discussion — and Who Should Not
May be reasonable to discuss
- A confirmed lungs disease diagnosis, with the patient medically stable and not in an acute emergency
- Prior imaging, neurology, and treatment records available for review
- The injury is past its acute phase, with the patient in a stable, chronic-care stage
- Realistic expectations that any benefit would be supportive and investigational, not a cure
- Willingness to continue rehabilitation and follow-up care alongside this discussion
Generally not appropriate
- Acute or unstable neurological emergencies requiring immediate critical care
- Active untreated infection, uncontrolled bleeding disorder, or advanced organ failure
- An active, untreated malignancy that has not been cleared by an oncologist
- Pregnancy, or an expectation that the therapy will reverse or cure the underlying condition
- Unwillingness to share prior medical records or to be evaluated before proceeding
This list is general and educational — it is not a substitute for an individual medical evaluation of your case.
13What a Lungs Disease Supportive-Care Discussion Involves
A supportive-care discussion for Lungs Disease isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:
- Record review: Your existing diagnosis, imaging, lab work, and treatment history for Lungs Disease are reviewed by the medical team first.
- Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
- Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
- Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
- Ongoing standard care continues: At every stage, your prescribed treatment for Lungs Disease continues unless your own treating specialist changes it.
Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.
14Our Approach to Lungs Disease Care
Stem Cell Care India states that its aim is to be available to patients throughout preparation and treatment, to prioritise patient wellbeing in every recommendation, to follow safety and quality standards at each stage, and to provide continued support through post-treatment follow-up.
15Cost and How Stem Cell Therapy Compares for Lungs Disease
The cost of treatment depends on the nature of the condition, the patient’s medical history, the number of cells required, and the patient’s overall physical condition. Patients are encouraged to book a free consultation to obtain a personalised cost estimate before committing to treatment.
16What Influences Lungs Disease Outcomes
There is currently no cure for COPD in conventional or regenerative medicine; management focuses on symptom control. Reported post-treatment observations at the clinic include improved pulmonary efficiency in some patients, reduced reliance on inhalers, and better self-reported quality of life — outcomes that should be understood as individual clinic experience rather than results from controlled clinical trials.
17Why Lungs Disease Patients Consider Treatment in India
- Typically involves a short, three-day hospital stay
- Uses the patient’s own cells, reducing rejection risk
- Positioned as a lower-cost alternative to some conventional long-term treatment regimens
- Delivered directly to, or near, the affected tissue
18Quality Control in Cell Processing for Lungs Disease Therapy
- All stem cell batches are screened for microbial pathogens before use
- Cells and culture media are tested for bacterial and mycoplasma contamination
- Endotoxin screening is carried out, with strict threshold limits
- Each batch is accompanied by a Certificate of Analysis
19What Lungs Disease Patients May Notice After Treatment
Interstitial lung disease and COPD together affect a large global population, with symptoms ranging from persistent breathlessness to chest tightness. The clinic reports that post-treatment patients typically describe improved breathing, stamina and coughing, most returning home within three days, with longer stays reserved for more complex cases.
20Lungs Disease Patient Experiences
Garima Matta (Delhi, India): Sought stem cell therapy after finding the cost of treatment elsewhere too high, and reports being able to breathe more easily since starting treatment at a more affordable price point.
Jovan Bliss (Fort Wayne, Indiana): Describes years of frustration with medication that brought little relief, and says stem cell therapy for lung disease gave noticeable relief in breathing.
Dominic Hale (Scotland): Lived with COPD for several years and reports easier breathing and more energy after a course of stem cell therapy, praising the clinic’s care throughout.
Mateus Silva (Brazil): Reports increased energy and fewer breathing difficulties following treatment, allowing more daily activity without early fatigue.
Carlos Ferreira (Portugal): Traveled from Portugal for treatment and reports a gradual decrease in breathing and coughing symptoms, with clear guidance from doctors on next steps.
21Quality Certification for Lungs Disease Therapy
A quality certificate is intended to document that the cell-processing steps used for a given batch were carried out under stated laboratory protocols and that the resulting cells met the facility's internal quality checks. Stem Cell Care India states that its cell-processing procedures are documented in this way, that patients are not charged extra for this documentation, and that equipment used is checked ahead of each procedure.
The clinic describes this certification as reflecting ethical practice, with patient safety, informed consent, and clear information treated as priorities, alongside ongoing internal checks on quality and procedure. This documentation reflects internal laboratory quality assurance rather than a government approval of the therapy itself for curing Lungs Disease, and a supporting team of medical staff is described as being available throughout the process.
22Lungs Disease Follow-Up Care
Stem Cell Care India states that it stays in touch with patients after treatment, monitoring breathing and general health, and offering guidance on medication, diet, breathing exercises and lifestyle changes that support recovery. Patients are asked to share medical reports and progress updates periodically.
23Supportive Therapies Sometimes Used Alongside Lungs Disease Treatment
Stem cell therapy is generally discussed as one part of a broader recovery plan rather than a stand-alone treatment. Supportive therapies sometimes used alongside it for lungs disease include:
- Psychological support: To help address mood changes, anxiety, or emotional stress that can follow a lungs disease.
- Speech therapy: For patients experiencing difficulty speaking, swallowing, or understanding language.
- Physiotherapy: To help rebuild movement, balance, and muscle strength.
- Hyperbaric oxygen therapy: Delivering oxygen at increased pressure, which is being explored as a supportive measure for tissue recovery.
- Acupuncture: Used by some patients as a complementary approach alongside conventional care.
- Rehabilitation therapy: Structured practice of daily tasks to support functional recovery.
- Occupational therapy: Support for relearning tasks such as dressing, eating, and writing.
- Nutrition therapy: Dietary guidance intended to support general recovery.
- Nerve Growth Factor (NGF) treatment: Supports the survival and growth of nerve cells; when discussed alongside stem cell therapy, it is explored for its potential to support nerve repair and overall brain recovery.
Any combination of these should be planned together with the treating medical team rather than pursued independently.
24Why Some International Lungs Disease Patients Consider India
International patients cite lower treatment costs, modern hospital infrastructure, experienced specialists, individualised treatment plans and shorter waiting times as reasons for choosing India for stem cell therapy related to lung disease, alongside complementary offerings such as yoga, Ayurveda and physiotherapy.
25Conclusion: Stem Cell Therapy for Lungs Disease
COPD remains a serious, life-limiting lung condition with no current cure, but early diagnosis and consistent management can meaningfully affect quality of life.
Stem cell therapy is being explored as a supportive option alongside standard treatment, with the aim of easing inflammation and supporting repair of damaged lung tissue, though the evidence base remains limited and results vary by patient.
Lifestyle changes — particularly quitting smoking, avoiding polluted air, eating well and staying active within safe limits — remain central to managing COPD regardless of which treatments are pursued.
Not sure if this applies to your case?
Share your diagnosis and reports, and our medical team will get back to you with a free, doctor-reviewed opinion on Lungs Disease — no obligation.
- Reviewed by our in-house medical team
- Doctor-reviewed reply within 24–48 hours
- No cost and no obligation to proceed
- Your information is kept confidential
Get Your Free Evaluation
Frequently Asked Questions
COPD is a progressive lung condition that includes emphysema and chronic bronchitis, marked by worsening airflow limitation and breathlessness. It is a leading cause of death worldwide and typically requires ongoing medical management.
Bronchodilators, inhalers, oral steroids and, in advanced cases, oxygen therapy or surgery. These manage symptoms but do not reverse existing lung damage, which is why interest in regenerative approaches has grown.
Adult stem cells sourced from the patient’s own adipose tissue or bone marrow are being studied for their potential to reduce inflammation and support repair of damaged airway and alveolar tissue, though this remains an early-stage, investigational approach rather than an established cure.
This varies by disease severity and individual response; some patients report gradual improvement in breathing comfort over weeks to months, but results are not guaranteed and should be discussed with a specialist.
Age, long-term smoking, occupational exposure to irritants, and genetic predisposition are the most commonly cited risk factors.
Through spirometry (lung function testing), chest X-ray or CT imaging, and blood gas analysis.
Medically reviewed by the Stem Cell Care India clinical team. Last reviewed 2 September 2026. Written by Nishat Arfin · Scientific review by Tabish Iqbal · Medically approved by the Stem Cell Care India Medical Team.
Investigational-status disclaimer. This content is for informational and educational purposes only. Stem cell therapy for Lungs Disease is considered investigational under current medical guidelines in India and is not FDA-approved. No guarantees or claims of cure are made. Results vary from patient to patient. Please consult a qualified healthcare professional before making any medical decisions.